Harvard Research Lab Secures $39 Million Lifeline from Private Equity, Ushering in New Era of Funding
Harvard Research Lab Secures $39 Million Lifeline from Private Equity, Ushering in New Era of Funding Facing funding cuts, Harvard University’s genetics and metabolism research is receiving a major boost. İş Private Equity, a Turkish firm, has committed $39 million to a lab led by Professor Gökhan Hotamışlıgil at the T.H. Chan School of Public Health. This isn’t just a financial injection; it’s a groundbreaking partnership. The investment will not only support Professor Hotamışlıgil’s crucial research but also fuel the…